No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Tyra Biosciences Reports Increased R&D Investment in Q1 2025
Tyra Biosciences to Participate at Upcoming Investor Conferences
Oppenheimer Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Cuts Target Price to $30
One Tyra Biosciences Insider Raised Stake By 284% In Previous Year
Express News | Tyra Biosciences Inc Files for Mixed Shelf of up to $500 Mln - SEC Filing
Express News | Tyra Biosciences Inc: Cash Runway Through at Least 2027